Healthy Q2 results; now all eyes on forest valuation review
28/08/19 -"After an extraordinary H2 18, performance normalisation has been picking up momentum in 2019. Yet, despite softening markets, SCA managed to attain an impressive Q2 performance. Continuation of the ..."
Pages
52
Language
English
Published on
28/08/19
You may also be interested by these reports :
08/11/19
Ever since mighty Essity (ADD, Sweden) demerged from SCA (ADD, Sweden) in June 2017, it seemed that the former – driven by sacrosanct global ‘health ...
01/11/19
Even though market conditions have become tougher, UPM managed to limit its Q3 business impact via effective cost savings. Interestingly, management ...
31/10/19
As expected, pricing normalisation is gathering momentum across the respective divisions. Yet, SCA’s Q3 profitability exceeded consensus estimates ...
30/10/19
Q3 performance came under (more-than-expected) pressure due to price and volume headwinds across most divisions. The dismal Q4 performance outlook ...